2-丙烯-1-酮,3-(1,3-苯并二噁唑-5-基)-1-(3-氯苯基)- | 169804-58-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 中文名称: 2-丙烯-1-酮,3-(1,3-苯并二噁唑-5-基)-1-(3-氯苯基)-
• 英文名称: 3-(1,3-Benzodioxol-5-yl)-1-(3-chlorophenyl)prop-2-en-1-one
• CAS: 169804-58-4
• 化学式: C₁₆H₁₁ClO₃
• 分子量: 286.715
• InChiKey: OCCMFZYYKQSDFH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-丙烯-1-酮,3-(1,3-苯并二噁唑-5-基)-1-(3-氯苯基)- 在 1-羟基苯并三唑 、 一水合肼 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 反应 28.0h， 生成 (5-(benzo[d][1,3]dioxol-5-yl)-3-(3-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)(3,4,5-trimethoxyphenyl)methanone
  参考文献：
  名称：

  Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors

  摘要：

  A series of novel pyrazoline-containing derivatives (15-47) has been designed, synthesized and evaluated for their biological activities. Among them, compound 18 displayed the most potent antiproliferative activity against A549, MCF-7 and HepG-2 cells line (IC50 = 0.07 mu M, 0.05 mu M, 0.03 mu M, respectively) and the tubulin polymerization inhibitory activity (IC50 = 1.88 mu M), being comparable to CA-4. Furthermore, we also tested that compound 18 was a potent inducer of apoptosis in HepG-2 cells and it had cellular effects typical for microtubule interacting agents, causing accumulation of cells in the G2/M phase of the cell cycle. These studies, along with molecular docking, provided a new molecular scaffold for the further development of antitumor agents that target tubulin. (C) 2015 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2015.02.058
• 作为产物：
  描述：

  3,4-二羟基苯甲醛 在 potassium carbonate 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 4.0h， 生成 2-丙烯-1-酮,3-(1,3-苯并二噁唑-5-基)-1-(3-氯苯基)-
  参考文献：
  名称：

  Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors

  摘要：

  A series of novel pyrazoline-containing derivatives (15-47) has been designed, synthesized and evaluated for their biological activities. Among them, compound 18 displayed the most potent antiproliferative activity against A549, MCF-7 and HepG-2 cells line (IC50 = 0.07 mu M, 0.05 mu M, 0.03 mu M, respectively) and the tubulin polymerization inhibitory activity (IC50 = 1.88 mu M), being comparable to CA-4. Furthermore, we also tested that compound 18 was a potent inducer of apoptosis in HepG-2 cells and it had cellular effects typical for microtubule interacting agents, causing accumulation of cells in the G2/M phase of the cell cycle. These studies, along with molecular docking, provided a new molecular scaffold for the further development of antitumor agents that target tubulin. (C) 2015 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2015.02.058